CN101439112A - Medicament for treating leukoderma - Google Patents
Medicament for treating leukoderma Download PDFInfo
- Publication number
- CN101439112A CN101439112A CNA2008102387329A CN200810238732A CN101439112A CN 101439112 A CN101439112 A CN 101439112A CN A2008102387329 A CNA2008102387329 A CN A2008102387329A CN 200810238732 A CN200810238732 A CN 200810238732A CN 101439112 A CN101439112 A CN 101439112A
- Authority
- CN
- China
- Prior art keywords
- gram
- medicine
- traditional chinese
- chinese medicine
- decoction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a new medicine for treating leukoderma, which belongs to the field of the traditional Chinese medicine technology and is prepared by taking squama manitis, turtle blood, scorpion, toad skin, fig, centipede, peach kernel, almond, honeycomb, spider, ginseng, radix scutellariae, liquorice, sow and larva of a silkworm withbatrytis as raw materials according to different characteristics of every traditional Chinese medicine in proportion. The raw materials are decocted, filtered, bottled, sterilized, and prepared into the traditional Chinese medicine decoction according to the conventional method. The medicine is the traditional Chinese medicine preparation and is formulated according to traditional Chinese medical theory, has reasonable drug selection, supplements qi and activats blood, and treats both principal and secondary aspect of disease. The medicine is proved to have obvious effect by clinically observing patients for many years, and has obvious effect on leukoderma caused by various reasons. The invention has exclusive prescription and has obvious effect.
Description
Technical field the invention belongs to technical field of Chinese medicines, relates to the leukodermal medicine of a kind of treatment, is the Chinese patent medicine of feedstock production specifically with the Chinese herbal medicine.
The background technology leukoderma is how because of due to QI and blood internal resistance, the pigementation.At present, it is more to treat leukodermal medicine, but mostly is Western medicine greatly.The side effect that the long-term excessive use of the leukodermal medicine of western medicine is brought is obvious to all, directly influences people's physical and mental health, directly brings spirit and burden economically for patient and family.
It is the leukodermal medicine of treatment of the rule of treatment that summary of the invention the purpose of this invention is to provide a kind of promoting blood circulation with lively atmosphere, to overcome the deficiencies in the prior art.
The objective of the invention is according to motherland's traditional medicine leukodermal pathogenetic understanding and Therapeutic Principle thereof, with reference to modern pharmacological research, therefrom filter out blood circulation promoting and blood stasis dispelling, the unobstructed natural Chinese medicinal herb of QI and blood, press the Chinese medical theory prescription, make its performance eliminate the effect of pigementation.
Medicine of the present invention is the medicament of being made by following raw materials by weight proportions
Squama Manis 10 gram turtle blood 10 gram Scorpios 10 gram Cutis Bufonis 500 gram Fructus Ficis 30 grams
Scolopendra 5 gram Semen Persicaes 10 gram Semen Armeniacae Amarums 10 gram honeycombs 5 gram Araneas 5 gram Radix Ginsengs 10 grams
Radix Scutellariae 10 gram Radix Glycyrrhizaes 10 gram ground beetles 30 gram Rhizoma Zingiberis Recens silkworms 10 grams
Above-mentioned each component is made Chinese medicine decoction according to a conventional method, finishes by following step successively:
1) decoct: above-mentioned all medicines are put into marmite or rustless steel pressure cooker, add hydrology fire by 1: 2 of medicine total amount and decoct, boiled back 20 minutes, medicinal liquid is leached, 1: 1 by the medicine total amount adds the fiery decoction of the hydrology again, boils back 20 minutes, and medicinal liquid is leached;
2) bottling: seal in the disinfectant bottle in advance with packing into behind twice filtrate mixing;
3) sterilization: the medicinal liquid bottle is put into pressure cooker sterilization 20 minutes, promptly get Chinese medicine medicine decoction of the present invention.
Medicine of the present invention is a Chinese medicine preparation, according to the theory of Chinese medical science prescription, selects that medicine is reasonable, dosage form is advanced, benefiting QI for activating blood circulation, treating both the principal and secondary aspects of a disease.Medicine of the present invention is through clinical observation patient for many years, and evident in efficacy, the leukoderma patient that a variety of causes is caused has remarkable result.
Clinical drug of the present invention is taken the result and is shown, following advantage is arranged:
1, to select natural plant for use be raw material in the present invention, and each component meets the pharmaceutical control law regulation, utilizes the comprehensive function treatment leukoderma of the medicine of respectively distinguishing the flavor of, and no chemicals is nontoxic to human body, has no side effect, and is safe and reliable.
2, slow fire of the present invention is fried in shallow oil water, and effective ingredient scatters and disappears few, and the curative effect height is cheap, taking convenience, no any discomfort disease.
3, medicine of the present invention is obvious to the leukoderma curative effect.
4, clinical drug of the present invention is observed, and can replace the leukodermal medicine of other treatment.
For showing that medicine of the present invention is to leukodermal therapeutic effect, the present invention is through the clinical observation of 500 routine leukoderma patient systems, and select medical history, the state of an illness, age, sex and leukoderma patient 100 examples suitable to organize as a comparison with traditional therapy, wherein male 200 examples, woman's 300 examples, 25～50 years old age, course of disease February～5 year.Test group: the conventional medicine of stopping using, take medicine of the present invention; Matched group: take conventional medicine.Observation period is 1 month, checks after half a year, does not have recurrence and is produce effects, and sb.'s illness took a favorable turn is evident as effectively, and it is not obvious that sb.'s illness took a favorable turn is invalid.
Instructions of taking a: 50ml, 3 times on the one, warm water delivery service.Clinical realization the results are shown in Table 1.
Table 1: take medicine of the present invention and take the observation of curative effect of conventional medicine to the leukoderma patient.
| Group | Case load | Produce effects (routine number) | Effectively (routine number) | Invalid (routine number) | Total effective rate (%) |
| Test group | 500 | 239 | 261 | 0 | 100 |
| Matched group | 100 | 0 | 78 | 22 | 78.0 |
| T | 2.50 | 5.68 | 2.30 | 3.89 | |
| P | <0.05 | <0.05 | <0.05 | <0.05 | <0.05 |
As can be seen from Table 1, medicine of the present invention is obtained 239 examples that have of significant curative effect to 500 routine leukoderma patients, accounts for 47.8%; That takes a turn for the better has 261 examples, accounts for 52.2%; Total effective rate reaches 100%.
The specific embodiment
Take by weighing raw material by following proportioning:
Squama Manis 10 gram turtle blood 10 gram Scorpios 10 gram Cutis Bufonis 500 gram Fructus Ficis 30 grams
Scolopendra 5 gram Semen Persicaes 10 gram Semen Armeniacae Amarums 10 gram honeycombs 5 gram Araneas 5 gram Radix Ginsengs 10 grams
Radix Scutellariae 10 gram Radix Glycyrrhizaes 10 gram ground beetles 30 gram Rhizoma Zingiberis Recens silkworms 10 grams
Above-mentioned each component is made Chinese medicine decoction according to a conventional method, finishes by following step successively:
1) decoct: above-mentioned all medicines are put into marmite or rustless steel pressure cooker, add hydrology fire by the 1:2 of medicine total amount and decoct, boiled back 20 minutes, medicinal liquid is leached, the 1:1 by the medicine total amount adds the decoction of hydrology fire again, boils back 20 minutes, and medicinal liquid is leached;
2) bottling: seal in the disinfectant bottle in advance with packing into behind twice filtrate mixing;
3) sterilization: the medicinal liquid bottle is put into pressure cooker sterilization 20 minutes, promptly get Chinese medicine medicine decoction of the present invention.
Claims (1)
1, the leukodermal medicine of a kind of treatment is characterized in that it is the decoction of being made by following raw materials by weight proportions: Squama Manis 10 gram turtle blood 10 gram Scorpios 10 gram Cutis Bufonis 500 gram Fructus Ficis 30 gram Scolopendras 5 gram Semen Persicaes 10 gram Semen Armeniacae Amarums 10 gram honeycombs 5 gram Araneas 5 gram Radix Ginsengs 10 gram Radix Scutellariaes 10 gram Radix Glycyrrhizaes 10 gram ground beetles 30 gram Rhizoma Zingiberis Recens silkworms 10 grams; Successively by the preparation of following step: 1) decoct: above-mentioned all medicines are put into marmite or rustless steel pressure cooker, add the fiery decoction of the hydrology, boiled back 20 minutes by 1: 2 of medicine total amount, medicinal liquid is leached, by the medicine total amount 1: 1 adds the decoction of hydrology fire again, boils back 20 minutes, and medicinal liquid is leached; 2) bottling: seal in the disinfectant bottle in advance with packing into behind twice filtrate mixing; 3) sterilization: the medicinal liquid bottle is put into pressure cooker sterilization 20 minutes, get final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008102387329A CN101439112B (en) | 2008-12-23 | 2008-12-23 | Medicament for treating leukoderma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008102387329A CN101439112B (en) | 2008-12-23 | 2008-12-23 | Medicament for treating leukoderma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101439112A true CN101439112A (en) | 2009-05-27 |
| CN101439112B CN101439112B (en) | 2011-07-20 |
Family
ID=40723810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008102387329A Expired - Fee Related CN101439112B (en) | 2008-12-23 | 2008-12-23 | Medicament for treating leukoderma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101439112B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105012566A (en) * | 2015-08-11 | 2015-11-04 | 李荣华 | External preparation for treating leukoderma and preparation method |
| CN105497155A (en) * | 2014-11-27 | 2016-04-20 | 印文敏 | Traditional Chinese medicine for treating oral leukoplakia |
| KR102199082B1 (en) * | 2019-07-11 | 2021-01-06 | 인하대학교 산학협력단 | Pharmaceutical composition for preventing or treating vitiligo or canities comprising extract of Prunus armeniaca as an active ingredient |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1063967C (en) * | 1998-10-21 | 2001-04-04 | 余际康 | Oral medicine for curing dermatosis |
| CN101297946B (en) * | 2008-06-24 | 2011-05-25 | 孙兆印 | Plaster for activating blood and resolving stasis, dispelling wind and freeing collateral vessels and producing method thereof |
-
2008
- 2008-12-23 CN CN2008102387329A patent/CN101439112B/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105497155A (en) * | 2014-11-27 | 2016-04-20 | 印文敏 | Traditional Chinese medicine for treating oral leukoplakia |
| CN105012566A (en) * | 2015-08-11 | 2015-11-04 | 李荣华 | External preparation for treating leukoderma and preparation method |
| KR102199082B1 (en) * | 2019-07-11 | 2021-01-06 | 인하대학교 산학협력단 | Pharmaceutical composition for preventing or treating vitiligo or canities comprising extract of Prunus armeniaca as an active ingredient |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101439112B (en) | 2011-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102430052A (en) | Traditional Chinese medicine for treating hand-foot-mouth disease | |
| CN103990036A (en) | Traditional Chinese medicine composition for relieving menstrual pain and preparation method and application thereof | |
| CN101670060A (en) | Traditional Chinese medicine composition for treating such diseases as hepatic stagnation, chest stuffiness and distension and preparation method | |
| CN103933468A (en) | Traditional Chinese medicine for treating acute pancreatitis | |
| CN102526677B (en) | Chinese medicine foot-massage composition for treating common cold due to wind-cold | |
| CN101439112B (en) | Medicament for treating leukoderma | |
| CN102357240A (en) | Traditional Chinese medicine for treating peripheral vascular functional disease of Raynaud disease | |
| CN102949700A (en) | Chinese medicinal preparation for treating cold stuffy nasal obstruction | |
| CN101411832A (en) | Medicament for treating chronic gastritis | |
| CN101411770B (en) | Medicament for treating blood stasis accumulation type multiple sclerosis symptoms | |
| CN101411831B (en) | Medicament for treating low fever | |
| CN101411824B (en) | Medicament for treating galactocele | |
| CN101411810B (en) | Medicament for treating multiple sclerosis symptoms | |
| CN100493571C (en) | Medicine for treating heart failure | |
| CN104225197A (en) | Traditional Chinese medicine for treating tinnitus cerebri caused by syndrome of qi depression transforming into fire | |
| CN104208385A (en) | Chinese medicinal drug for treating phlegm-dampness stagnation syndrome type tinnitus cerebri | |
| CN101417095B (en) | Medicine for treating arthrodynia | |
| CN102362953A (en) | Chinese medicine for treating cytomegalovirus (CMV) pneumonia after renal transplantation | |
| CN101244194B (en) | Chinese medicine for treating scrofula disease | |
| CN100551389C (en) | A kind of medicine for the treatment of early bone tumor | |
| CN101411859B (en) | Chinese medicine preparation for treating dysmenorrhea | |
| CN102885955B (en) | Medicament for treating pulmonary actinomycosis infection after kidney transplantation operation | |
| CN102908598B (en) | Medicine for treating children fungal pneumonia | |
| CN103157040A (en) | Pharmaceutical composition for treating multiple osteoenchondroma | |
| CN103655875B (en) | Treatment blood sampling causes the medicine of Patients with Aplastic Anemia venous thrombosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Chen Jianmin Inventor after: Feng Peizhi Inventor after: Wang Zhongchun Inventor before: Wang Xuling Inventor before: Feng Peizhi Inventor before: Wang Zhongchun Inventor before: Chen Jianmin |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG XULING FENG PEIZHI WANG ZHONGCHUN CHEN JIANMIN TO: CHEN JIANMIN FENG PEIZHI WANG ZHONGCHUN |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110720 Termination date: 20111223 |